Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia. 1982

C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava

Jejunal mucosal crypts were examined in jejunal biopsies from eight children with acute lymphoblastic leukaemia who had recently received methotrexate treatment. By comparison with biopsies from children under investigation for suspected malabsorption crypt mitosis was significantly reduced and showed a negative correlation with the dose of methotrexate given prior to biopsy. The three major cell types were studied under light and transmission electron microscopy. Gut endocrine cells were unaffected by therapy and immature crypt enterocytes showed only patchy degenerative abnormalities. By contrast a number of Paneth cells showed striking structural alterations with vacuolar dilatation of the cytoplasm. The extent of this correlated with the time since methotrexate treatment rather than its dose and may have been a functional response rather than of a toxic nature.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008940 Mitotic Index An expression of the number of mitoses found in a stated number of cells. Index, Mitotic,Indices, Mitotic,Mitotic Indices
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
December 1977, British medical journal,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
July 1981, Journal of clinical pathology,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
October 1980, British journal of cancer,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
January 2006, Clinical pharmacokinetics,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
January 1979, Cancer chemotherapy and pharmacology,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
January 1987, Cancer chemotherapy and pharmacology,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
March 2005, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
March 1993, British journal of haematology,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
February 1982, British journal of cancer,
C R Pinkerton, and C H Cameron, and J M Sloan, and J F Glasgow, and N J Gwevava
April 2000, Medical and pediatric oncology,
Copied contents to your clipboard!